This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 103/7/717    most recent CIRCRESAHA.108.182899v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahmoudi, M. Articles by Bennett, M. Search for Related Content PubMed PubMed Citation Articles by Mahmoudi, M. Articles by Bennett, M. Related Collections Pathophysiology Smooth muscle proliferation and differentiation Chronic ischemic heart disease

(Circulation Research. 2008;103:717.)
© 2008 American Heart Association, Inc.

Molecular Medicine

Statins Use a Novel Nijmegen Breakage Syndrome-1–Dependent Pathway to Accelerate DNA Repair in Vascular Smooth Muscle Cells

Melli Mahmoudi, Isabelle Gorenne, John Mercer, Nicola Figg, Trevor Littlewood, Martin Bennett

From the Division of Cardiovascular Medicine, University of Cambridge, United Kingdom.

Correspondence to Prof Martin Bennett, Division of Cardiovascular Medicine, University of Cambridge, Box 110, Addenbrooke’s Hospital, Cambridge, CB2 2QQ, United Kingdom. E-mail mrb{at}mole.bio.cam.ac.uk

Although the hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are widely used in atherosclerosis to reduce serum cholesterol, statins have multiple other effects, including direct effects on cells of the vessel wall. Recently, DNA damage, including telomere shortening, has been identified in vascular smooth muscle cells (VSMCs) in human atherosclerosis. Although statins reduce DNA damage in vitro, the mechanisms by which they might protect DNA integrity in VSMCs are unknown. We show that human atherosclerotic plaque VSMCs exhibit increased levels of double-stranded DNA breaks and basal activation of DNA repair pathways involving ataxia telangiectasia–mutated (ATM) and the histone H2AX in vivo and in vitro. Oxidant stress induced DNA damage and activated DNA repair pathways in VSMCs. Statin treatment did not reduce oxidant stress or DNA damage but markedly accelerated DNA repair. Accelerated DNA repair required both the Nijmegen breakage syndrome (NBS)-1 protein and the human double minute protein Hdm2, accompanied by phosphorylation of Hdm2, dissociation of NBS-1 and Hdm2, inhibition of NBS-1 degradation, and accelerated phosphorylation of ATM. Statin treatment reduced VSMC senescence and telomere attrition in culture, accelerated DNA repair and reduced apoptosis in vivo after irradiation, and reduced ATM/ATR (ATM and Rad3-related) activity in atherosclerosis. We conclude that statins activate a novel mechanism of accelerating DNA repair, dependent on NBS-1 stabilization and Hdm2. Statin treatment may delay cell senescence and promote DNA repair in atherosclerosis.

Key Words: atherosclerosis • vascular smooth muscle • aging • oxidant stress

This article has been cited by other articles:

				H. Oeseburg, D. Iusuf, P. van der Harst, W. H. van Gilst, R. H. Henning, and A. J.M. Roks Bradykinin Protects Against Oxidative Stress-Induced Endothelial Cell Senescence Hypertension, February 1, 2009; 53(2): 417 - 422. [Abstract] [Full Text] [PDF]